1. Field of the Invention
The present disclosure is related to auto-injection devices. More particularly, the present disclosure is related to a coupling for auto-injection devices for releasably securing an injection spring to a plunger rod.
2. Description of Related Art
Diseases such as AIDS, Hepatitis, and others, are increasing within the general population. The onset of these diseases has increased the desire to prevent inadvertent needle sticks during the use of syringe assemblies. Many prior art devices include self-retracting needles to mitigate inadvertent needle sticks.
Many life-threatening situations such as allergy induced anaphylactic shock, and exposure to chemical, radiological, and biological weapons can require the use of automatic injection devices. Also, many non-threatening conditions can be candidates for use of such automatic injection devices. However, the cost of the prior art automatic injection device can make such use by consumers cost prohibitive.
Typical automatic injection devices are syringe assemblies that allow the medically untrained user to automatically inject a medicine by manually trigging the automatic injection. Some prior automatic injection devices also incorporate self-retracting needles. Such automatic injection and retraction assemblies included a coupling that releasably couples an injection spring to a syringe plunger. Unfortunately, many prior couplings require tight manufacturing tolerances, which can increase the overall cost of the device.
Accordingly, there is a continuing need for auto-injection devices and couplings for such devices that overcome and/or mitigate one or more of the aforementioned and other deficiencies and deleterious effects of prior automatic injection devices.
It is an object of the present disclosure to provide a coupling for selectively securing a spring to a plunger. The coupling has a first end defining a spring rest for receiving the spring and a second end defining a shoulder. The shoulder is moveable to a first position into contact with the plunger and to a second position out of contact with the plunger. The shoulder is normally in the second position and is resiliently moveable to the first position.
In some embodiments, the coupling includes a first end defining a spring rest for receiving the spring and a second end defining a shoulder. The spring rest and the shoulder are radially offset from one another by a predetermined angle.
In other embodiments, the coupling includes a first end defining a pair of spring rests for receiving the spring and a second end defining a pair of shoulders. The pair of shoulders are moveable to a first position into contact with the plunger and a second position out of contact with the plunger.
A power injection assembly is also provided. The assembly includes a plunger rod, an injection spring, an inner housing, and a coupling. The plunger rod has a rib. The inner housing has a first opening and an inner diameter. The injection spring is about the inner housing and the plunger rod is in the inner diameter. The coupling has a spring rest and a shoulder. The coupling is in the inner diameter such that the spring rest extends through the first opening and receives the injection spring and such that the shoulder is compressed to a first position by the inner diameter. The shoulder is engaged with the rib in the first position.
The above-described and other features and advantages of the present disclosure will be appreciated and understood by those skilled in the art from the following detailed description, drawings, and appended claims.
Referring to the figures and in particular to
Auto-injection device 10 is configured to extend a hypodermic needle from within the device, inject a single, pre-measured dose of medicine from cartridge 14 into a user, and automatically retract the hypodermic needle into the device after the injection is completed.
Advantageously, syringe assembly 10 is a multi-component device that can be assembled by the user and/or medical provided (e.g., pharmacist, doctor, nurse). Since syringe assembly 10 does not require assembly at the time of manufacture, the present disclosure effectively separates expiry of medicine cartridge 14 from the expiry of syringe assembly 10. For example, typical flu vaccines have an expiration date of one year. Thus, the user can maintain a supply of power injection and retraction assemblies 12, 16 of the present disclosure, while only replacing any expired medicine cartridges 14.
For example, power-injection assembly 12 and power-retraction assembly 16 can be secured to one another in a snap fit manner so that the assemblies can not be removed from one another after injection. In the illustrated embodiment, power-injection assembly 12 includes one or more outwardly depending tabs 18 that are received in a corresponding number of openings 20 defined in power-retraction assembly 16. As power-injection assembly 12 is inserted into power-retraction assembly 16, tabs 18 act on the power-retraction assembly to elastically deform the inner dimension of the tube. Once tabs 18 are received by openings 20, the inner dimension of power-retraction assembly 16 resiliently returns to its original dimension to secure the tabs in the openings.
In the assembled state, syringe assembly 10 preferably maintains cartridge 14 hermetically sealed between power-injection and retraction assemblies 12, 16. For example, power-injection assembly 12 can include a sealing member 22 such as, but not limited to an o-ring. Once power-injection assembly 12 and power-retraction assembly 16 are secured together, sealing member 22 cooperates with the interior of the power-retraction assembly to form a hermetic radial seal. In the illustrated embodiment, sealing member 22 is positioned below openings 20 defined in power-retraction assembly 16 to provide the hermetic seal below the snap fit connection between tabs 18 and openings 20.
The operation of the power-injection assembly 12 is described with simultaneous reference to
Activation device 28 has an upper end 32 and a lower end 34. Injection assembly 12 is activated by depressing activation device 28 in direction 48. In addition, activation device 28 can include an outer shroud 36. Outer shroud 36 and injection assembly 12 can include one or more cooperating guides (not shown) that permit depression of activation device 28 only after the activation device has been rotated to a predetermined position. In sum, outer shroud 36 and injection assembly 12 can work together to require movement in two directions, rotation and depression, in order to activate injection spring 24. In a preferred embodiment, shroud 36 includes a number of longitudinal ribs 38 to assist the user in rotation. In this manner, injection assembly 12 is particularly suited for use in situations where the user may lack typical manual dexterity, such as can be the case where the user is wherein protective gloves.
Lower end 34 is configured to selectively couple the energy from injection spring 24 to drive plunger rod 26. In the illustrated embodiment, plunger rod 26 includes a driving end 38 and a locking end 40. Locking end 40 includes two tines 42 that are resiliently biased outward so that the tines are remote from one another. Driving end 38 is configured to act on medicine cartridge 14 in a known manner. For example, driving end 38 can act on medicine cartridge 14 as described in U.S. Pat. No. 6,387,078.
Injection assembly 12 includes a locking member 44 that engages tines 42 when the tines are normally biased from one another. Activation device 28 includes a releasing surface 46 defined at lower end 34. Force applied to upper end 32 of activation device 28 in direction 48 causes releasing surface 46 to compress tines 42 toward one another such that the tines are disengaged from locking member 44.
Injection spring 24 is maintained in a normally compressed or stressed condition. Upon release of tines 42 from locking member 44, the stored energy in spring 24 drives plunger rod 26 in an injection direction 48.
Coupling 30 includes a first end 50 and a second end 52. First end 50 forms a spring rest or seat 51 upon which injection spring 24 rests as shown in
Second end 52 (shown in
During movement of plunger rod 26 in injection direction 48, second end 52 is maintained in the compressed position and, thus, shoulder 53 is maintained engaged with rib 54 so that the force of injection spring 24 is transmitted through coupling 30 to plunger rod 26.
After plunger rod 26 has traveled a predetermined distance, second end 52 is allowed to bias outward away from rod 26 so that shoulder 53 disengages from rib 54 as shown in
Preferably, coupling 30 includes a pair of spring rests 51 and a pair of shoulders 53. Here, spring rests 51 are, preferably, diametrically opposed to one another. Similarly, shoulders 53 are, preferably, diametrically opposed to one another. Moreover, spring rests 51 are, preferably, radially offset from shoulders 53 by a predetermined angle, preferably about 90 degrees. In this manner, each spring rest 51 is offset from each shoulder 53 by about by about 90 degrees.
Spring rests 51 are, preferably, axially offset from shoulders 53 by a predetermined distance so that coupling 30 has an axial length. In this manner, spring rests 51 are disposed forward relative to shoulders 53 along the axial length so that spring 24 encompasses a portion of the axial length.
For applications involving auto-injection devices 10 for small dose volumes deposited at shallow depths, the demand on injection spring 24, in terms of the spring rate and extension length, are not very severe. Thus, injection spring 24 can be incorporated into power-injection assembly 12 with a reasonable set of device proportions (e.g., length and diameter). However, in cases with auto-injection devices 10 that must deliver larger dose volumes deposited at deeper needle penetration depths, the demand on injection spring 24, in terms of the spring rate and extension length, can be severe. In these applications, injection spring 24 requires a long travel and high spring rate. This combination of high spring rate and long travel typically requires injection spring 24 to be a long, slender spring positioned in straight line sequence with the plunger, which unfortunately leads to power-injection assembly 12 having an undesireably long length. Alternately, the combination of high spring rate and long travel typically requires injection spring 24 to have a large diameter.
Advantageously, coupling 30 is particularly suited for use with such large diameter springs. Specifically, coupling 30 has spring rests 51 that are disposed radially outward from the coupling and are disposed forward of shoulders 53. In this manner, injection spring 24 encompasses a portion of the axial length of coupling 30 so that the larger diameter spring axially overlaps at least a portion of plunger rod 26. According, coupling 30 finds particular use with large diameter springs to mitigate the overall length of power-injection assembly 12.
In the illustrated embodiment, injection assembly 12 includes an inner housing 56 shown in
Inner housing 56 has an inner diameter 60 that is sufficient to maintain second end 52 of coupling 30 in the compressed position and, thus, engaged with plunger rod 26. Thus, second end 52 is outwardly biased against inner diameter 60 of inner housing 56. The force of injection spring 24 is sufficient to overcome the friction between second end 52 and housing 56.
Inner housing 56 also includes a second opening 62. Preferably, inner housing 56 has a pair of second openings 62 that are defined through the inner housing diametrically opposed to one another. Second opening 62 is offset from first opening 58 by the same predetermined angle that offsets spring rest 51 from shoulder 53. Thus, second opening 62 is aligned with shoulder 53 of coupling 30.
Second opening 62 is defined at a predefined position along injection direction 48 where it is desired for coupling 30 to disengage injection spring 24. Thus, after plunger rod 26 has traveled to the point where second end 52 of coupling 30 is at second opening 62, the second end 52 is no longer maintained in the compressed position by inner diameter 60, which allows the second end to resiliently bias outward to the first position through the second opening and move shoulder 53 out of engagement with rib 54.
Advantageously, coupling 30 can be made of any material having sufficient resiliency to bias second end 52 outward at second opening 62. For example, coupling 30 can be made of spring steel stamped into the desired shape such as that illustrated in
In this manner, injection spring 24 drives plunger rod 26 in injection direction 48 until second end 52 of coupling 30 reaches second opening 52. The resiliency of coupling 30 causes the coupling to expand through second opening 52 and disengage shoulder 53 from rib 54 of plunger rod 26 as seen in
Retraction assembly 16 can operate in a known manner. For example, power-retraction assembly 16 can include a retraction spring (not shown) that has a spring force lower than the spring force of injection spring 24. Thus, injection spring 24 overcomes the force of the retraction spring as long as coupling 30 engages plunger rod 26 to the injection spring. However, once second end 52 of coupling 30 is disengaged from plunger rod 26 and the force of injection spring 24 is no longer transmitted through the coupling to the plunger rod, the force of the retraction spring is sufficient to urge medicine cartridge 14 in a direction opposite injection direction 48, thus automatically retracting the hypodermic needle of cartridge 14 into device 10.
It should be noted that the terms “first”, “second”, “third”, “upper”, “lower”, and the like may be used herein to modify various elements. These modifiers do not imply a spatial, sequential, or hierarchical order to the modified elements unless specifically stated.
While the present disclosure has been described with reference to one or more exemplary embodiments, it will be understood by those skilled in the art that various changes may be made and equivalents may be substituted for elements thereof without departing from the scope of the present disclosure. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the disclosure without departing from the scope thereof. Therefore, it is intended that the present disclosure not be limited to the particular embodiment(s) disclosed as the best mode contemplated, but that the disclosure will include all embodiments falling within the scope of the appended claims.
This application claims priority of U.S. Provisional Application Ser. No. 60/634,486 filed on Dec. 9, 2004 and is related to commonly owned and assigned U.S. application Ser. No. 10/601,212, filed Jun. 20, 2003, the contents of both of which are incorporated by reference herein.
Number | Date | Country | |
---|---|---|---|
60634486 | Dec 2004 | US |